Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.420
-0.010 (-0.41%)
At close: Feb 3, 2025, 4:00 PM
2.450
+0.030 (1.24%)
After-hours: Feb 3, 2025, 7:53 PM EST
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 208 employees as of December 31, 2023. The number of employees increased by 11 or 5.58% compared to the previous year.
Employees
208
Change (1Y)
11
Growth (1Y)
5.58%
Revenue / Employee
$219,553
Profits / Employee
-$46,183
Market Cap
178.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PLX News
- 6 weeks ago - Protalix BioTherapeutics Issues 2025 Letter to Stockholders - PRNewsWire
- 2 months ago - Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa - PRNewsWire
- 2 months ago - Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results - PRNewsWire
- 3 months ago - Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024 - PRNewsWire
- 3 months ago - Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024 - PRNewsWire
- 4 months ago - Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm - Business Wire
- 5 months ago - Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024 - GlobeNewsWire